Imipramine N-oxide hydrate

CAS: 6829-98-7

Ref. 3D-FI24562

Información del producto

• Nombre: Imipramine N-oxide hydrate
• Sinónimos: 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine N-Oxide hydrate, 10,11-Dihydro-N,N-dimethyl-5H-dibenz(b,f)azepine-5-propanamine N-oxide, 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine 5-oxide, 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine N-oxide, 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, N-oxide, 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, N-oxide, Elepsin, Imipramine N-oxide, Imipramine oxide, Imipraminoxide [INN], Imipraminoxido, Imipraminoxido [INN-Spanish], Imipraminoxidum, Imipraminoxidum [INN-Latin], N,N-dimethyl-3-(5-oxido-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-amine, Unii-8Mks280Xjw, [3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]dimethylamine oxide, Imipraminoxide

Descripción

Imipramine N-oxide hydrate is a polymer drug that belongs to the group of amines. It inhibits the activity of CYP450 enzymes and has been shown to be effective in treating inflammatory bowel disease (IBD). Imipramine N-oxide hydrate prevents adenosine A3 receptor activation and suppresses the production of dinucleotide phosphate, which may be responsible for its effectiveness in treating IBD. Imipramine N-oxide hydrate also has an effect on liver cells, which may lead to its effectiveness in treating infectious diseases. The drug is not active against autoimmune diseases, but it may have an effect on toll-like receptors.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 296.41 g/mol
• Fórmula: C₁₉H₂₄N₂O·xH₂O
• Pureza: Min. 95%
• Color/Forma: White Powder